ZoomInfo Grew Revenue Just 1.5% Amid $17M Share Selloff
A large fund sold about $17 million in ZoomInfo shares while the company posted slim revenue growth. This article bre...
Fund Activity
Explore four Fund Activity articles that summarize recent capital moves, new fund bets, and biotech deals. This page helps you spot trends that affect your investments.
12 articlesErasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
This Biotech Stock Winner Is Up 72%, but Trim Signals Reset
A biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
This Life Sciences Supplier Plunges 50% as Fund Buys Stock
A leading life sciences supplier has seen its stock fall sharply over the past year. At the same time, a hedge fund s...
Port Capital Doubles Down on Atmus Filtration Technologies
Institutional funds often reveal conviction through large stake increases. This article explains the implications whe...
Turning Point Brands Stock Soars as Fund Sells $12.5M
Turning Point Brands stock has surged, even as a prominent fund dumped millions in TPB shares. This article breaks do...
Sable Offshore Stock Tanked: What Investors Should Know
Sable Offshore stock tanked over the last year as oil markets swung and investors weighed long-term offshore exposure...
Sotera Health This Past Year: Why a Fund Sold $4 Million
Sotera Health has delivered a solid return over the last 12 months. Yet a sizable fund recently unloaded millions of ...
Capital Sold Victoria’s Secret: Is This Stock a Buy or Sell?
A notable stake change in Victoria’s Secret & Co. raises questions for investors. This article explains what the capi...
Fund Builds Million Commerce Stake as SPS Stock Slumps
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Related Topics
#Investing (8)
#Portfolio Management (5)
#Stock Analysis (3)
#Stock Market (2)
#Stocks (2)
#Biotech Investing (2)
#Biotech Stocks (2)
#Portfolio Strategy (1)
#Energy Stocks (1)
#Stock Picks (1)
#SaaS (1)
#Market Analysis (1)
#Investing Strategies (1)
#Investing Strategy (1)
#portfolio-allocation (1)